Aaron has been involved in clinical research since 2002, having worked his way up from research assistant to program manager in academia before pivoting to industry in 2014. He comes to Eradivir, Inc. with a wealth of experience in operationalizing clinical trials, ranging from investigator-initiated pilot studies through global Phase 3 clinical programs (and everything in-between) at start-ups and big pharma. An alumnus of the University of Pennsylvania and La Salle University, he is proud to have notched several successful NDAs and spends his free time pretending to be a musician.